chr7-144397452-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001080413.3(NOBOX):​c.1864G>A​(p.Asp622Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000217 in 1,384,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000022 ( 0 hom. )

Consequence

NOBOX
NM_001080413.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.21

Publications

0 publications found
Variant links:
Genes affected
NOBOX (HGNC:22448): (NOBOX oogenesis homeobox) This homeobox gene encodes a transcription factor that is thought to play a role in oogenesis. In mice, it is essential for folliculogenesis and regulation of oocyte-specific genes. Defects in this gene result in premature ovarian failure type 5.[provided by RefSeq, May 2011]
NOBOX Gene-Disease associations (from GenCC):
  • premature ovarian failure 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.09380907).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOBOXNM_001080413.3 linkc.1864G>A p.Asp622Asn missense_variant Exon 10 of 10 ENST00000467773.1 NP_001073882.3 O60393-1
NOBOXNM_001436401.1 linkc.1513G>A p.Asp505Asn missense_variant Exon 8 of 8 NP_001423330.1
NOBOXNM_001436402.1 linkc.961G>A p.Asp321Asn missense_variant Exon 7 of 7 NP_001423331.1
NOBOXXM_017011742.3 linkc.1768G>A p.Asp590Asn missense_variant Exon 10 of 10 XP_016867231.1 O60393-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOBOXENST00000467773.1 linkc.1864G>A p.Asp622Asn missense_variant Exon 10 of 10 5 NM_001080413.3 ENSP00000419457.1 O60393-1
NOBOXENST00000483238.5 linkc.1768G>A p.Asp590Asn missense_variant Exon 10 of 10 5 ENSP00000419565.1 O60393-2
NOBOXENST00000645489.1 linkc.1513G>A p.Asp505Asn missense_variant Exon 8 of 8 ENSP00000496732.1 A0A2R8Y8C8
NOBOXENST00000643164.1 linkc.*59G>A downstream_gene_variant ENSP00000495343.1 A0A2R8Y683

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000217
AC:
3
AN:
1384916
Hom.:
0
Cov.:
31
AF XY:
0.00000439
AC XY:
3
AN XY:
683392
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31594
American (AMR)
AF:
0.00
AC:
0
AN:
35698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35734
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34998
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00000185
AC:
2
AN:
1078868
Other (OTH)
AF:
0.00
AC:
0
AN:
57912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 08, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1864G>A (p.D622N) alteration is located in exon 10 (coding exon 10) of the NOBOX gene. This alteration results from a G to A substitution at nucleotide position 1864, causing the aspartic acid (D) at amino acid position 622 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.087
.;.;T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.75
FATHMM_MKL
Benign
0.043
N
LIST_S2
Benign
0.72
T;T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.094
T;T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Benign
0.90
.;.;L
PhyloP100
1.2
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.3
.;N;N
REVEL
Benign
0.15
Sift
Benign
0.078
.;T;T
Sift4G
Benign
0.68
.;T;T
Vest4
0.15, 0.17
MutPred
0.12
.;.;Loss of phosphorylation at Y624 (P = 0.0779);
MVP
0.70
MPC
0.029
ClinPred
0.12
T
GERP RS
1.7
Varity_R
0.052
gMVP
0.10
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2053901115; hg19: chr7-144094545; API